In clinical trials, 87% of diabetic participants on Retatrutide achieved A1C levels under 7.0%, which is the standard diabetes control target recommended by the Canadian Diabetes Association
It is only accessible through participation in authorised clinical trials
However, this effect can also lead to gastrointestinal adverse effects, including nausea, vomiting, diarrhoea, and constipation , which are among the most commonly reported side effects
While semaglutide and tirzepatide focus primarily on GLP-1 and GIP pathways, this peptide also activates the glucagon receptor, which boosts energy expenditure and weight reduction
GLP-1s are contraindicated in some thyroid cancers
Estudos * mostram que no processo de emagrecimento as dietas com maior teor proteico ajudam a preservar massa magra, sustentam a saciedade e favorecem melhor manuteno do peso aps a perda